Company: PSTV
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001193125-25-258596
Chunk: 0

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-10-30
Form: 10-Q
Item: Item 1
Chunk 0
---
PLUS THERAPEUTICS, INC. 

 CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(in thousands, except share and par value data)

     September 30, 2025

     December 31, 2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     13,289

     $
     76

     Investments

     3,312

     3,530

     Grant receivable

     —

     571

     Other current assets

     985

     1,082

     Total current assets

     17,586

     5,259

     Property and equipment, net

     273

     448

     Operating lease right-of-use assets

     20

     73

     Goodwill

     372

     372

     Intangible assets, net

     374

     469

     Other assets

     45

     12

     Total assets
      
     $
     18,670

     $
     6,633

     Liabilities and Stockholders’ Equity (Deficit)

     Current liabilities:

     Accounts payable and accrued expenses
      
     $
     11,623

     $
     11,288

     Operating lease liability

     21

     44

     Deferred grant liability

     1,972

     927

     Line of credit

     —

     3,292

     Total current liabilities

     13,616

     15,551

     Noncurrent operating lease liability

     —

     31

     Total liabilities

     13,616

     15,582

     Commitments and contingencies (Note 8)

     Stockholders’ equity (deficit):

     Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,952 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

     —

     —

     Common stock, $0.001 par value; 2,000,000,000 shares authorized; 131,863,969 shares issued; and 131,605,544 shares outstanding as of September 30, 2025, and 100,000,00 shares authorized; 6,154,758 shares issued;